Log In
Print this Print this

oxycodone/naltrexone (ELI-201)

  Manage Alerts
Collapse Summary General Information
Company Elite Pharmaceuticals Inc.
DescriptionAbuse-deterrent formulation of oxycodone and naltrexone
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPivotal
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today